首页> Leukemia> KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.

导出 OA

翻译打印收藏纠错

第一作者： K,Malinowska-Ozdowy

第一单位： Children's Cancer Research Institute (CCRI), Leukemia Biology Group, Vienna, Austria.

作者： K,Malinowska-Ozdowy ^[1] ; C,Frech ^[1] ; A,Schönegger ^[2] ; C,Eckert ^[3] ; G,Cazzaniga ^[4] ; M,Stanulla ^[5] ; U,zur Stadt ^[6] ; A,Mecklenbräuker ^[1] ; M,Schuster ^[2] ; D,Kneidinger ^[1] ; A,von Stackelberg ^[3] ; F,Locatelli ^[7] ; M,Schrappe ^[8] ; M A,Horstmann ^[6] ; A,Attarbaschi ^[9] ; C,Bock ^[2] ; G,Mann ^[9] ; O A,Haas ^[10] ; R,Panzer-Grümayer ^[1]

作者单位： Children's Cancer Research Institute (CCRI), Leukemia Biology Group, Vienna, Austria. ^[1] Research Center for Molecular Medicine (CeMM), Vienna, Austria. ^[2] Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany. ^[3] Centro Ricerca Tettamanti, University of Milano-Bicocca, Ospedale San Gerardo, Monza, Italy. ^[4] Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany. ^[5] Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[6] Department of Pediatric Hematology-Oncology, IRCCS Bambino Gesù Hospital, Rome, Italy. ^[7] Department of Pediatrics, Medical University of Schleswig Holstein, Kiel, Germany. ^[8] St. Anna Kinderspital, Medical University Vienna, Vienna, Austria. ^[9] 1] Children's Cancer Research Institute (CCRI), Leukemia Biology Group, Vienna, Austria [2] St. Anna Kinderspital, Medical University Vienna, Vienna, Austria. ^[10]